Latest revenue
$1.24B
as of 2026-03-31
Latest net income
$-71.0M
as of 2026-03-31
Net margin
-5.7%
as of 2026-03-31
Community sentiment
Where do you think BLCO is heading?
Keep private notes on BLCO — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
BLCO vs S&P 500 · rebased to 100
Market data
Price feed temporarily unavailable for BLCO.
What this company does
Item 1. Business Bausch + Lomb Corporation (and its subsidiaries) (“Bausch + Lomb,” “we,” “us,” “our” or the “Company”) is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Our mission is simple, yet powerful: helping you see better, to live better. Founded in 1853, Bausch + Lomb has a significant global research, development, manufacturing and commercial footprint of approximately 13,000 employees and a presence in approximately 100 countries. As a fully integrated eye health business, Bausch + Lomb has a comprehensive portfolio of approximately 400 products, which includes an established…
AI summary unavailable — showing raw filing excerpt
Generated from BLCO's filing dated 2026-02-18
Key risks
Item 1A. Risk Factors Our business, financial condition, cash flows and results of operations are subject to various risks and uncertainties. You should carefully consider the risks and uncertainties described below, together with all of the other information in this Form 10-K, including those risks set forth under the heading entitled “Forward-Looking Statements” and in other documents that we file with the SEC and the CSA, before making any investment decision with respect to our common shares or debt securities. If any of the risks or uncertainties actually occur or develop, our business, financial condition, cash flows, results of operations and/or future growth prospects could change,…
AI summary unavailable — showing raw filing excerpt
Generated from BLCO's filing dated 2026-02-18
ActaClear Score
Computed from 5 years of SEC fundamentals + latest market data, ranked within Ophthalmic Goods (7 peers). 10 = best in industry, 5 = median, 0 = worst. Refreshed Jun 10, 2026.